Related Experiment Video
Updated: Mar 13, 2026
12:11
Analysis of Chromosome Segregation, Histone Acetylation, and Spindle Morphology in Horse Oocytes
Published on: May 11, 2017
11.5K
Transcriptome analysis of equine sarcoids
1Department of Genomics and Molecular Biology of Animals, National Research Institute of Animal Production, Balice, Poland.
Veterinary and Comparative Oncology
|October 26, 2016
Summary
Researchers analyzed gene expression in equine sarcoids, identifying 901 differentially expressed genes (DEGs). This comparative transcriptomic analysis offers insights into horse skin tumor biology and potential cancer biomarkers.
Area of Science:
- Veterinary Oncology
- Equine Genetics
- Comparative Transcriptomics
Background:
- Equine sarcoids are the most common skin tumors in horses.
- Understanding the molecular basis of these tumors is crucial for developing diagnostic and therapeutic strategies.
Purpose of the Study:
- To perform a comparative transcriptomic analysis of equine sarcoids and healthy skin.
- To identify differentially expressed genes (DEGs) and pathways associated with tumor development and progression.
- To discover potential cancer-specific genes that could serve as biomarkers for equine skin tumors.
Main Methods:
- Utilized Horse Gene Expression Microarray data from matched equine sarcoid and healthy skin samples.
- Conducted a comparative analysis to identify significantly differentially expressed genes (DEGs).
- Statistical analysis with a fold change threshold of ≥2 and P-value <0.05 was applied.
Main Results:
- Identified 901 significantly differentially expressed genes (DEGs) between lesional and healthy skin samples.
- A substantial subset of DEGs showed decreased expression, potentially indicating suppressed malignant transformation.
- Several overexpressed genes were linked to tumor growth, progression, and immune system activity.
Conclusions:
- This study presents a comprehensive transcriptome analysis of equine skin tumors.
- Pinpointed significant molecular pathways and genes involved in equine oncogenesis.
- The identified DEGs and pathways offer potential targets for diagnostic biomarkers and therapeutic interventions in equine sarcoids.
